Perhaps I'll start, and then others can respond.
As I mentioned earlier on the WTO waiver decision, in light of the concern that there was a need in developing countries but that there was this existing international intellectual property obligation system in place and the model was not going to be revamped entirely, the decision was carefully defined and limited to provide this limited exception to existing intellectual property rights and standards.
Within that carefully defined model and structure, certain obligations were waived under the WTO decision, but it was specifically stated that the intent of the waiver was to respond to a country's need for a particular amount of drugs. To allow for an unlimited export may not be in the spirit of that decision.